These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4071323)

  • 1. Comparison of haemoglobin levels and blood-transfusion requirements in patients on haemodialysis and on chronic ambulatory peritoneal dialysis.
    Naiker IP; Seedat YK
    S Afr Med J; 1985 Nov; 68(11):785-6. PubMed ID: 4071323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAPD versus haemodialysis: a comparison in the same patients.
    Morduchowicz G; Winkler J; Boner G
    Int Urol Nephrol; 1992; 24(5):575-9. PubMed ID: 1459836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD.
    Sotirakopoulos N; Athanasiou G; Tsitsios T; Mavromatidis K
    Ren Fail; 2002 Jul; 24(4):505-10. PubMed ID: 12212830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the hematocrit response to continuous ambulatory peritoneal dialysis.
    Steiner RW
    Arch Intern Med; 1984 Apr; 144(4):728-32. PubMed ID: 6712371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
    Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
    Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients.
    Summerfield GP; Gyde OH; Forbes AM; Goldsmith HJ; Bellingham AJ
    Scand J Haematol; 1983 Apr; 30(4):389-400. PubMed ID: 6344194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is anaemia during continuous ambulatory peritoneal dialysis really better than during haemodialysis?
    Salahudeen AK; Keavey PM; Hawkins T; Wilkinson R
    Lancet; 1983 Nov; 2(8358):1046-9. PubMed ID: 6138598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does increasing haemoglobin concentration and haematocrit have a pressor effect in dialysis patients?
    Williams B; Edmunds ME; Thompson JP; Burton PR; Feehally J; Walls J
    Nephrol Dial Transplant; 1989; 4(9):787-91. PubMed ID: 2516610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy.
    Aikhionbare HA; Winterborn MW; Gyde OH
    Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on the plasma clearance of an albumin-bound furan dicarboxylic acid.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1995; 10(5):648-52. PubMed ID: 7566577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
    Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
    Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant human erythropoietin in end stage renal disease.
    Conlon PJ; Walshe JJ; O'Donnell R; O'Donohoe A; Spencer R; Donohoe J; Carmody M
    Ir J Med Sci; 1993 Jan; 162(1):17-9. PubMed ID: 8440603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Tokuda Y; Itou H; Uchida Y; Azuma K; Ohtsuka H; Uomizu K; Yamashita W; Harada R; Nakashima A; Morita T
    Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Mariak I
    Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
    Siu YP; Leung KT; Tong MK; Kwan TH; Mok CC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2797-802. PubMed ID: 16204302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.